For years, the ECG market was relatively static. According to a new report, however, things are rapidly changing. 

In a new poll, more insured adults listed receiving coverage approval for treatment and medications as the single largest burden they face when navigating the U.S. healthcare system than any other issue. KFF found that 47% experienced “denied, delayed or altered” patient care over the last two years. 

Physicians made their plea in in the February issue of the JACR, which is focused on the “Economics of Education,” and meant to spark “dialogue around how radiology education is valued, supported and delivered.” 

E-mails sent to the full workforce at hospitals and health systems are costly due to the time they take away from recipients’ other essential duties and tasks. How costly? Researchers have done the math.

Discounts represent out-of-pocket costs and come in the form of direct-to-consumer sales through manufacturer websites or via a coupon. AstraZeneca, Eli Lilly, EMD Serono, Novo Nordisk and Pfizer have all listed some of their most popular drugs on the TrumpRx.gov portal.

The Federal Trade Commission was suing the pharmacy benefit manager over allegations it was deliberately inflating the price of insulin. Per the agreement, Express Scripts has agreed to end business practices that involved taking manufacturer rebates on wholesale drug costs without passing them on to patients.

Regardless of hospital size, per-patient-discharge costs are affected by two factors sometimes understood to exist in tension with one another. 

Medtronic has held a minority investment in CathWorks for several years, and the two organizations entered into a co-promotion agreement in 2022. Once finalized, the move will increase Medtronic's presence in the cath lab.